Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
GILA MONSTER Heloderma suspectum Petitioned USFWS Distinguishing Features The Gila monster is a large, heavy- bodied lizard reaching a little over 1¼ feet in length. The head is large, with small, beady eyes; the tail is short and fat. The family name Helodermatidae means “warty skin,” referring to the beaded look of the dorsal scales, due to the presence of osteoderms (small bones) under the scales. The lizard is bright pink and black, usually in a reticulated pattern, but in a banded pattern in some populations. Range The bulk of this lizard’s range is in western and southern Arizona, continuing to southern Sonora, Mexico, but it can also be found in extreme southeastern California, southern Nevada, extreme southwestern Utah, and southwestern New Mexico. Drug research In 2005, the U.S. Food and Drug Administration approved the drug exenatide (marketed as Byetta) for the management of type 2 diabetes. It is a synthetic version of a protein, exendin-4, derived from the Gila monster's saliva. In a three-year study with people with type 2 diabetes, exenatide led to healthy sustained glucose levels and progressive weight loss. The effectiveness is due to the fact that the lizard protein is about 50 percent identical to glucagon-like peptide-1 analog (GLP-1), a hormone released from the human digestive tract that helps to regulate insulin and glucagon. The lizard protein remains effective much longer than the human hormone, helping diabetics keep their blood sugar levels under control. Exenatide slows the emptying of the stomach and causes a decrease in appetite, contributing to weight loss.